http://www.jneuroengrehab.com/content/12/1/57
We recently completed a Phase I clinical trial which examined the safety of a BCI-FES system for dorsiflexion therapy in chronic stroke survivors. Applying the BCI-FES therapy not only appeared to be safe, but may also lead to an increase in gait velocity. Additional study will be necessary to examine the potential efficacy of this therapy. The paper can be viewed by going to the link above.